BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24593796)

  • 1. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
    Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
    Ishii K; Soma T; Kono AK; Sofue K; Miyamoto N; Yoshikawa T; Mori E; Murase K
    J Nucl Med; 2007 May; 48(5):704-11. PubMed ID: 17475957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
    Okamura N; Arai H; Higuchi M; Tashiro M; Matsui T; Hu XS; Takeda A; Itoh M; Sasaki H
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):447-56. PubMed ID: 11294488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography.
    Imamura T; Ishii K; Hirono N; Hashimoto M; Tanimukai S; Kazui H; Hanihara T; Sasaki M; Mori E
    Dement Geriatr Cogn Disord; 2001; 12(3):194-7. PubMed ID: 11244212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
    J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies.
    Kang S; Jeon S; Lee YG; Ye BS
    Alzheimers Res Ther; 2024 Apr; 16(1):89. PubMed ID: 38654300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
    Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
    Kono AK; Ishii K; Sofue K; Miyamoto N; Sakamoto S; Mori E
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1490-7. PubMed ID: 17318545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
    Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
    Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
    Mosconi L; Tsui WH; Herholz K; Pupi A; Drzezga A; Lucignani G; Reiman EM; Holthoff V; Kalbe E; Sorbi S; Diehl-Schmid J; Perneczky R; Clerici F; Caselli R; Beuthien-Baumann B; Kurz A; Minoshima S; de Leon MJ
    J Nucl Med; 2008 Mar; 49(3):390-8. PubMed ID: 18287270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies.
    Singh NA; Goodrich AW; Graff-Radford J; Machulda MM; Sintini I; Carlos AF; Robinson CG; Reid RI; Lowe VJ; Jack CR; Petersen RC; Boeve BF; Josephs KA; Kantarci K; Whitwell JL
    Neuroimage; 2024 Apr; 290():120564. PubMed ID: 38442778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study.
    Perneczky R; Haussermann P; Diehl-Schmid J; Boecker H; Forstl H; Drzezga A; Kurz A
    Dement Geriatr Cogn Disord; 2007; 23(6):416-22. PubMed ID: 17457029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
    Nestor PJ; Caine D; Fryer TD; Clarke J; Hodges JR
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1521-9. PubMed ID: 14617709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.